{"id":"https://openalex.org/W2754469738","doi":"https://doi.org/10.2215/cjn.07680717","title":"Are SGLT2 Inhibitors Ready for Prime Time for CKD?","display_name":"Are SGLT2 Inhibitors Ready for Prime Time for CKD?","alternate_titles":[],"publication_year":2017,"publication_date":"2017-09-11","ids":{"openalex":"https://openalex.org/W2754469738","doi":"https://doi.org/10.2215/cjn.07680717","mag":"2754469738","pmid":"https://pubmed.ncbi.nlm.nih.gov/28893920","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5967433"},"language":"en","primary_location":{"id":"doi:10.2215/cjn.07680717","doi":"https://doi.org/10.2215/cjn.07680717","is_oa":false,"landing_page_url":"https://doi.org/10.2215/cjn.07680717","pdf_url":null,"source":{"id":"https://openalex.org/S184267533","display_name":"Clinical Journal of the American Society of Nephrology","issn_l":"1555-9041","issn":["1555-9041","1555-905X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Journal of the American Society of Nephrology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2754469738"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://europepmc.org/pmc/articles/PMC5967433","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038855428","display_name":"Roberto Pecoits\u2010Filho","orcid":"https://orcid.org/0000-0002-0255-6710","observed_orcids":["https://orcid.org/0000-0002-0255-6710"]},"institutions":[{"id":"https://openalex.org/I176838256","display_name":"Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1","ror":"https://ror.org/02x1vjk79","country_code":"BR","type":"education","lineage":["https://openalex.org/I176838256"]},{"id":"https://openalex.org/I4210110309","display_name":"The George Institute for Global Health","ror":"https://ror.org/023331s46","country_code":"AU","type":"facility","lineage":["https://openalex.org/I4210110309"]}],"countries":["AU","BR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Roberto Pecoits-Filho","raw_affiliation_strings":["George Institute for Global Health, Newtown, New South Wales, Australia;","School of Medicine, Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1, Curitiba, Brazil; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"George Institute for Global Health, Newtown, New South Wales, Australia;","institution_ids":["https://openalex.org/I4210110309"]},{"raw_affiliation_string":"School of Medicine, Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1, Curitiba, Brazil; and","institution_ids":["https://openalex.org/I176838256"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027520502","display_name":"Vlado Perkovic","orcid":"https://orcid.org/0000-0002-4257-7620","observed_orcids":["https://orcid.org/0000-0002-4257-7620"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]},{"id":"https://openalex.org/I4210110309","display_name":"The George Institute for Global Health","ror":"https://ror.org/023331s46","country_code":"AU","type":"facility","lineage":["https://openalex.org/I4210110309"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Vlado Perkovic","raw_affiliation_strings":["Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia","George Institute for Global Health, Newtown, New South Wales, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia","institution_ids":["https://openalex.org/I31746571"]},{"raw_affiliation_string":"George Institute for Global Health, Newtown, New South Wales, Australia;","institution_ids":["https://openalex.org/I4210110309"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5038855428"],"corresponding_institution_ids":["https://openalex.org/I176838256","https://openalex.org/I4210110309"],"apc_list":null,"apc_paid":null,"fwci":5.5648,"has_fulltext":false,"cited_by_count":35,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96200536,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"13","issue":"2","first_page":"318","last_page":"320"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.5479000210762024,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.5479000210762024,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.384799987077713,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10684","display_name":"Acute Kidney Injury Research","score":0.043299999088048935,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.996999979019165},{"id":"https://openalex.org/keywords/chronic-kidney-disease","display_name":"chronic kidney disease","score":0.9940000176429749},{"id":"https://openalex.org/keywords/acute-kidney-injury","display_name":"acute kidney injury","score":0.7699999809265137},{"id":"https://openalex.org/keywords/albuminuria","display_name":"albuminuria","score":0.7919999957084656},{"id":"https://openalex.org/keywords/glomerular-filtration-rate","display_name":"glomerular filtration rate","score":0.9359999895095825},{"id":"https://openalex.org/keywords/sodium-excretion","display_name":"sodium excretion","score":0.7599999904632568},{"id":"https://openalex.org/keywords/canagliflozin","display_name":"canagliflozin","score":0.8840000033378601},{"id":"https://openalex.org/keywords/dapagliflozin","display_name":"dapagliflozin","score":0.8109999895095825},{"id":"https://openalex.org/keywords/empagliflozin","display_name":"empagliflozin","score":0.8970000147819519},{"id":"https://openalex.org/keywords/cardiovascular-outcomes","display_name":"cardiovascular outcomes","score":0.4749999940395355},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.7310000061988831}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8928446769714355},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.7088644504547119},{"id":"https://openalex.org/C2776174234","wikidata":"https://www.wikidata.org/wiki/Q974792","display_name":"Albuminuria","level":3,"score":0.5962494611740112},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5562481880187988},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5173341631889343},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5172044038772583},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.5140691995620728},{"id":"https://openalex.org/C174459258","wikidata":"https://www.wikidata.org/wiki/Q6980232","display_name":"Natriuresis","level":3,"score":0.48905572295188904},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.4256626069545746},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.4130787253379822}],"mesh":[{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051297","descriptor_name":"Sodium-Glucose Transporter 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D051436","descriptor_name":"Renal Insufficiency, Chronic","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.2215/cjn.07680717","doi":"https://doi.org/10.2215/cjn.07680717","is_oa":false,"landing_page_url":"https://doi.org/10.2215/cjn.07680717","pdf_url":null,"source":{"id":"https://openalex.org/S184267533","display_name":"Clinical Journal of the American Society of Nephrology","issn_l":"1555-9041","issn":["1555-9041","1555-905X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Journal of the American Society of Nephrology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5342988","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC5967433","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5967433","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5967433/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin J Am Soc Nephrol","raw_type":"Text"},{"id":"pmid:28893920","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28893920","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical journal of the American Society of Nephrology : CJASN","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:5342988","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC5967433","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"},{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"},{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"},{"id":"https://openalex.org/F4320327235","display_name":"Servier","ror":"https://ror.org/034e7c066"},{"id":"https://openalex.org/F4320330753","display_name":"Akebia Therapeutics","ror":"https://ror.org/003br8b23"},{"id":"https://openalex.org/F4320334874","display_name":"Defense Acquisition Program Administration","ror":"https://ror.org/04bjg9m96"},{"id":"https://openalex.org/F4320336263","display_name":"Relypsa","ror":"https://ror.org/05japc090"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W1664963969","https://openalex.org/W2301210108","https://openalex.org/W2424539745","https://openalex.org/W2492672367","https://openalex.org/W2512006388","https://openalex.org/W2595201361","https://openalex.org/W2618856448","https://openalex.org/W2626446274","https://openalex.org/W3140572997"],"related_works":["https://openalex.org/W2492672367","https://openalex.org/W2012855857","https://openalex.org/W2901368325","https://openalex.org/W3012919507","https://openalex.org/W3003420651","https://openalex.org/W2464639624","https://openalex.org/W2050463609","https://openalex.org/W2917226491","https://openalex.org/W4398135650","https://openalex.org/W2563398804"],"abstract_inverted_index":{"Introduction":[0],"Sodium-glucose":[1],"cotransporter-2":[2],"(SGLT2)":[3],"is":[4,250,812,823,1561,1588,1593,1616,1624,1844,1904,1969,2010,2057],"a":[5,44,68,93,188,261,305,340,403,762,993,1108,1194,1246,1265,1294,1376,1427,1433,1440,1464,1544,1748,1845,1899,2061,2073,2292],"sodium-dependent":[6],"glucose":[7,2121],"transport":[8],"protein,":[9],"and":[10,24,83,115,147,156,234,271,380,425,477,485,524,534,544,582,757,877,897,968,971,1042,1086,1260,1425,1447,1456,1498,1535,1555,1604,1630,1657,1684,1709,1725,1834,1875,1887,1903,1971,2001,2027,2087,2096,2128,2164,2191,2200,2225,2235,2250,2252,2288],"its":[11,157,1908],"inhibitors":[12],"(SGLT2i":[13],"-":[14,394],"gliflozins)":[15],"are":[16,126,244,256,275,301,1367,1459,1478,1761,2118],"indicated":[17,92],"as":[18,185,187,1190,1515,1698,2016],"an":[19,173,650,972,2017,2119],"adjunct":[20],"therapy":[21,1351,1494,2123],"to":[22,75,151,199,230,332,390,566,586,604,617,631,645,668,714,755,888,919,984,1020,1067,1102,1136,1188,1199,1234,1243,1258,1284,1348,1370,1387,1463,1484,1506,1523,1528,1595,1667,1671,1678,1751,1764,1790,1850,1864,1906,1920,1979,1992,2023,2034,2059,2169,2298],"diet":[23],"exercise":[25],"for":[26,596,771,1272,1495,1584,1721,2124,2219,2244,2262],"improving":[27],"glycemic":[28,79,299,1930],"control":[29],"in":[30,98,108,116,165,176,192,236,258,277,292,376,591,615,640,652,683,744,766,782,790,798,806,813,824,835,859,880,900,911,956,1054,1076,1082,1087,1093,1107,1127,1269,1299,1352,1385,1407,1472,1501,1551,1567,1601,1606,1633,1652,1662,1737,1770,1837,1856,1866,1911,1963,1982,2004,2045,2065,2080,2114,2150,2159,2177,2195,2201],"type":[31,925],"2":[32,523,533,543,837,861,958,1409,1871],"diabetes":[33,923],"mellitus":[34,924],"(DM2).":[35],"In":[36,264,360,778,786,794,802,1286],"fact,":[37],"SGLT2i":[38,66,155,170,203,285,337,400,1318,1468,1626,1769,1916,2117,2194],"usage":[39],"has":[40,1893,1917,2090,2291],"been":[41,358,1306,1719,1918,2092],"associated":[42,128],"with":[43,103,129,260,279,294,362,479,487,882,966,1059,1121,1224,1227,1319,1354,1461,1474,1636,1664,1739,1747,1786,1839,1868,1901,1934,1965,2013,2070,2086,2126,2179,2197,2203],"robust":[45],"hemoglobin":[46],"A1c":[47],"(HbA1c)":[48],"reduction":[49,97,175,191,235,590,700,711,722,765,1268],"of":[50,56,60,64,70,132,154,208,314,319,329,350,397,547,569,575,607,633,649,660,672,674,677,701,703,712,723,725,747,761,784,792,800,808,870,873,892,942,974,997,1003,1032,1035,1071,1078,1089,1111,1116,1123,1166,1206,1211,1249,1251,1264,1288,1297,1317,1341,1423,1435,1442,1452,1467,1549,1575,1642,1695,1714,1768,1784,1793,1798,1803,1817,1827,1830,1854,1860,1884,1924,1929,1938,1940,1974,1996,2038,2041,2068,2075,2104,2107,2110,2133,2146,2174,2193,2294],"0.5%\u20130.6%,":[51],"sustained":[52,588,612,681,763,1266,2043],"over":[53,1325,1659,1811,1895],"52":[54],"weeks":[55,1661],"follow-up":[57],"(1).":[58],"Because":[59],"their":[61,1954],"unique":[62,1936],"mechanism":[63,1937],"action,":[65],"have":[67,287,357,1718],"range":[69],"effects":[71,89,243,255,320,941,1541,1612,1694,1730,1754,1799,1931],"that":[72,202,215,253,284,309,336,1144,1481,1532,1649,1691,1729,1778,1953],"may":[73,204,286,338,371,2165],"translate":[74,1958],"potential":[76,1465,2101,2168],"benefits":[77,300,2103],"beyond":[78],"control,":[80],"including":[81,402,1898],"BP":[82,100,110,266],"weight":[84,118],"reduction.":[85],"A":[86,696,886,1639,1990],"meta-analysis":[87],"assessing":[88,1313],"on":[90,159,246,273,321,353,850,875,894,944,1332,1343,1469,1542,1613,1731,1755,1832,1998,2077,2100,2211,2241,2254],"BP,":[91,1656,1708],"2.46":[94],"mm":[95,113],"Hg":[96],"systolic":[99],"following":[101],"treatment":[102,1301],"SGLT2i.":[104],"The":[105,195,1204,1450,1530,1825,1877,1987,2055],"mean":[106],"difference":[107],"diastolic":[109],"was":[111,119,1105,1222],"1.46":[112],"Hg,":[114],"body":[117,1654,1706],"1.88":[120],"kg":[121],"(2).":[122],"Interestingly,":[123,304],"these":[124,254,369,1152,1614,1941,2156],"factors":[125],"clearly":[127],"the":[130,145,166,206,241,312,327,334,348,351,373,387,398,408,570,592,594,646,653,669,675,678,745,758,767,769,871,890,938,950,989,1055,1083,1094,1112,1128,1140,1145,1161,1175,1207,1261,1300,1314,1329,1339,1401,1420,1453,1573,1579,1611,1634,1692,1727,1753,1766,1794,1801,1815,1828,1852,1858,1922,1935,1945,1951,1972,1994,2032,2035,2039,2066,2111,2129,2134,2144,2167,2172,2189],"risk":[131,207,459,463,467,475,483,491,699,710,721,996,1248,1363,1550,1632,2173],"not":[133,251,1156,1305,1504,1521],"only":[134],"cardiovascular":[135],"(CV)":[136],"disease,":[137,379,970,1360,1554],"but":[138,1557,1564,2141],"kidney":[139,160,289,296,315,341,355,378,384,404,940,945,1023,1040,1048,1153,1277,1321,1379,1396,1430,1436,1470,1502,1513,1553,1559,1569,1585,1629,1699,1741,1757,1771,1788,1804,1819,1861,1888,1925,1946,1961,2051,2062,2078,2082,2102,2148,2161,2175,2205],"disease":[140,471,1049,1586,2083],"also.":[141],"This":[142,1806],"article":[143],"reviews":[144],"current":[146,1349],"forthcoming":[148],"knowledge":[149,1479],"relating":[150],"clinical":[152,330,365,1647,1985],"trials":[153,331,366,1312,1458,1648,1780,1821,2163],"effect":[158,197,1340],"disease.":[161,1772,2206],"Main":[162],"Kidney":[163,492,908,913,1236,1365],"Findings":[164],"Published":[167],"Clinical":[168,420],"Trials":[169],"consistently":[171,1704],"cause":[172],"acute":[174],"GFR":[177,196,731],"by":[178],"approximately":[179],"5":[180],"ml/min":[181,497,502,507,512,518,528,538,619,738,978,1389,1673,1680,1686],"per":[182,498,503,508,513,519,529,539,620,739,815,817,826,979,1390,1674,1681,1687],"1.73":[183,499,504,509,514,520,530,540,621,740,818,980,1391,1675,1682,1688],"m2,":[184,981,1676,1683],"well":[186,1545],"consistent":[189,1538],"30%\u201340%":[190],"albuminuria":[193,268,584,748,1252],"(3).":[194],"led":[198],"initial":[200],"concern":[201],"increase":[205],"AKI.":[209],"These":[210,281,324],"data":[211,282,1292,1609],"support":[212],"mechanistic":[213],"studies":[214,346,370,401,1511,1746,2153],"suggest":[216,283,1143,2143],"proximal":[217],"tubular":[218],"natriuresis":[219],"activates":[220],"tubule-glomerular":[221],"feedback":[222],"through":[223],"increased":[224],"macula":[225],"densa":[226],"sodium":[227],"delivery,":[228],"leading":[229],"afferent":[231],"arteriole":[232],"vasoconstriction":[233],"intraglomerular":[237],"pressure":[238],"(4).":[239],"As":[240],"glycosuric":[242],"dependent":[245],"glomerular":[247],"filtration,":[248],"it":[249,1191],"surprising":[252],"attenuated":[257],"patients":[259,278,548,1080,1091,1118,1125,1185,1353,1576,1663,2012],"reduced":[262,295,1740,1787],"GFR.":[263],"contrast,":[265],"lowering,":[267],"lowering":[269,2122],"effects,":[270,290,1976],"impact":[272,349,1466,1853,1944,1955],"eGFR":[274,616,684,811,973,1386,1669],"preserved":[276],"CKD.":[280,1638],"beneficial":[288],"even":[291],"people":[293,1473,1738,2125,2178,2196,2202],"function,":[297,1789],"where":[298],"limited":[302],"(5).":[303],"recent":[306],"study":[307,1336,2056],"suggested":[308,1293],"canagliflozin":[310,1201,1225,1244,1855],"slows":[311],"progression":[313,713,746,1250,1859,1923],"function":[316,493,1700,1926],"decline":[317,682,732,1927,2044],"independently":[318,1928],"glycemia":[322],"(6).":[323,1932],"observations":[325],"motivated":[326],"development":[328],"test":[333,2155],"hypothesis":[335,1952],"be":[339,920,1148,1371,1485,1491,1776,1809,1823,1980],"protective":[342],"treatment.":[343],"Two":[344],"major":[345,399,998],"describing":[347],"drugs":[352],"long-term":[354,939],"outcomes":[356,946,1024,1154,1168,1237,1345,1366,1471,1560,1615,1734,1962,2079],"reported.":[359,1824],"combination":[361],"other":[363,382,1722],"ongoing":[364,1988],"(Table":[367,1913,2053],"1),":[368],"shift":[372],"therapeutic":[374],"paradigm":[375],"diabetic":[377,1552],"perhaps":[381,1499],"progressive":[383],"diseases,":[385],"expanding":[386],"options":[388],"available":[389,1810],"patients.":[391],"Table":[392],"1.":[393],"Comparative":[395],"description":[396],"endpoint":[405,656,1381,1583,1880],"Name":[406],"Of":[407],"Study":[409,887,1179,1991],"EMPA-REG":[410,828,1454,1533,1602],"OUTCOME":[411,1455,1534,1603],"CANVAS/CANVAS":[412,841],"R":[413],"DECLARE":[414,1374],"VERTIS":[415],"CREDENCE":[416],"DAPA-CKD":[417],"EMPAGLIFLOZIN":[418,904],"RENAL":[419],"trial":[421,1417,1843,1848,2074],"registration":[422],"NCT01131676":[423],"NCT01032629":[424],"NCT01989754":[426],"NCT01730534":[427],"NCT01986881":[428],"NCT02065791":[429],"NCT03036150":[430],"TBA":[431,557,694,810],"Intervention":[432],"Empagliflozin":[433,451,830,906,951,991],"versus":[434,437,440,443,446,449,452,706,717,728,736],"placebo":[435,438,441,444,447,450,453,1060,1095,1129,1228,1865,2026],"Canagliflozin":[436,445,843,874,1176,1831],"Dapagliflozin":[439,448,848,893,1330,1997],"Ertugliflozin":[442,857,1405],"Patient":[454],"population":[455,1635],"DM2,":[456,460,464,468,472,922,1869,2127],"high":[457,461,465,473,481,489],"CV":[458,462,466,474,482,490,628,665,689,969,1000,1008,1196,1214,1315,1344,1359,1362,1398,1421,1631,1890,2049,2139],"established":[469,1358,1637,2014,2081,2112,2198],"vascular":[470],"DM2":[476,484,967,1184,1355,1665],"nonpatients":[478,486,1964,2069],"diabetes,":[480,488],"inclusion":[494,2018],"criteria":[495],"eGFR\u226530":[496,501,506,511],"m2":[500,505,510,521,622,1392],"m3":[515,531],"30\u2265":[516,526,536],"eGFR\u226490":[517,527,537],"(CKD":[522,532,542],"3)":[525,535,545],"m4":[541],"Number":[546],"7021":[549],"10,142":[550],"17,276":[551],"8000":[552],"(estimated)":[553,556],"4461":[554],"4000":[555],"Prespecified":[558,1022],"renal":[559,580,601,608,626,634,636,663,692,776],"endpoints":[560,1322,1517,1758],"Incident":[561],"or":[562,577,598,627,638,664,685,688,691,773,988,1007,1027,1037,1046,1158,1202,1219,1274,1361,1397,1439,1796,1872,1889,2025,2048,2050],"worsening":[563,1028,1047],"nephropathy":[564,1029],"(progression":[565],"macroalbuminuria,":[567],"doubling":[568,659,702,1031,1441,1883],"serum":[571,642,661,930,1072,1885],"creatinine":[572,643,1073],"level,":[573],"initiation":[574,724,1034],"RRT,":[576,597,772,1036,1273],"death":[578,599,629,666,690,693,774,1009,1038,1212,1275,2052],"from":[579,600,775,949,1039,1213,1276,1308,2233],"disease)":[581,1041],"incident":[583,1026,1043],"Progression":[585],"albuminuria,":[587,1543],"40%":[589,764,1267],"eGFR,":[593,768,1270,2046],"need":[595,770,1271,1483,1978],"causes":[602,777,1278],"Time":[603,630,644,667],"first":[605,647,670,2036,2130],"event":[606,651],"composite":[609,632,655,759,1262,1380,1434,1879,2040],"endpoint:":[610],"Confirmed":[611],"\u226540%":[613,1383],"decrease":[614,734,1384,1628,1697],"eGFR<60":[618,1388],"and/or":[623,625,1393,1395,2214,2257],"ESRD":[624,687,1394],"death,":[635,1437],"dialysis/transplant,":[637],"\u22652\u00d7increase":[639],"baseline":[641,1443,1668],"occurrence":[648,671,2037],"primary":[654,1195,1208,1749,1878],"(primary)":[657],"ESRD,":[658,1438,1578,1882,2047],"creatinine,":[662,1033,1886],"any":[673,1975],"components":[676],"composite:":[679],"\u226550%":[680,2042],"reaching":[686,1577],"Outcomes":[695,855,879,896,1403,1836,2000],"44%":[697],"relative":[698,709,720,1863],"SCr":[704],"(1.5%":[705],"2.6%);":[707],"38%":[708],"macroalbuminuria":[715],"(11.2%":[716],"16.2%);":[718],"55%":[719],"RRT":[726,1104],"(0.3%":[727],"0.6%);":[729],"slowing":[730],"(annual":[733],"0.19\u00b10.11":[735],"1.67\u00b10.13":[737],"m2;":[741],"P<0.001).":[742,1069],"Reduction":[743],"(hazard":[749,1010],"ratio,":[750],"0.73;":[751,1254],"95%":[752,932,934,1014,1064,1099,1133,1231,1255,1281],"CI,":[753,933,1065,1100,1134,1232,1256,1282],"0.67":[754,1257],"0.79)":[756,1259],"outcome":[760,1209,1263,1570,1820,2162],"progress,":[779,787,795,803],"estimated":[780,788,796,804],"completion":[781,789,797,805],"April":[783],"2019":[785,793,801,1912],"October":[791],"June":[799],"November":[807],"2020":[809],"millimeters":[814],"minute":[816],"m2.":[819],"Urine":[820],"albumin-to-creatinine":[821,1711],"ratio":[822,1011,1712],"milligrams":[825],"gram.":[827],"OUTCOME,":[829],"Cardiovascular":[831,844,851,854,878,898,952,1177,1333,1402,1835,2002],"Outcome":[832,909,953],"Event":[833,954],"Trial":[834,907,910,955],"Type":[836,860,957,1408],"Diabetes":[838,862,959,1410],"Mellitus":[839,863,960,1411],"Patients;":[840],"R,":[842],"Assessment":[845,1178],"Study;":[846],"DECLARE,":[847],"Effect":[849,891,1331,1995],"Events;":[852],"VERTIS,":[853],"Following":[856,1404],"Treatment":[858,1406],"Participants":[864,881,965,1412,1838],"With":[865,902,1413,2006],"Vascular":[866,1414],"Disease;":[867,914],"CREDENCE,":[868],"Evaluation":[869,1826],"Effects":[872,1829],"Renal":[876,895,1833,1999],"Diabetic":[883,1840],"Nephropathy;":[884],"DAPA-CKD,":[885],"Evaluate":[889,1993],"Mortality":[899,2003],"Patients":[901,961,1241,2005],"CKD;":[903],"RENAL,":[905],"Chronic":[912],"NCT,":[915],"ClinicalTrials.gov":[916],"Identifier,":[917],"TBA,":[918],"announced;":[921],"2;":[926],"CV,":[927],"cardiovascular;":[928],"SCr,":[929],"creatinine;":[931],"confidence":[935,1015],"interval.":[936],"Firstly,":[937],"empagliflozin":[943,987,1056,1084,1113,2076],"were":[947,982,1155,1238,1520],"reported":[948,1307,1720],"(EmpaRegOutcome":[962],"Trial)":[963],"(7,8).":[964],"at":[975,2216,2259],"least":[976],"30":[977],"randomized":[983,1183,2022],"receive":[985,1200],"either":[986,1357],"placebo.":[990,1203],"demonstrated":[992],"significantly":[994],"lower":[995,1109,1223,1247],"adverse":[999,1289],"events,":[1001,1290],"consisting":[1002],"myocardial":[1004,1217],"infarction,":[1005,1218],"stroke,":[1006],"[HR],":[1012],"0.86;":[1013,1230],"interval":[1016],"[95%":[1017],"CI],":[1018],"0.74":[1019],"0.99).":[1021],"included":[1025,1193],"(macroalbuminuria,":[1030],"albuminuria.":[1044],"New":[1045],"occurred":[1050,1075],"less":[1051],"frequently":[1052],"(12.7%)":[1053],"group":[1057,1085,1096,1114],"compared":[1058,1120],"(18.8%)":[1061],"(HR,":[1062,1097,1131,1229,1253,1279],"0.61;":[1063],"0.53":[1066],"0.70;":[1068],"Doubling":[1070],"level":[1074],"70":[1077],"4645":[1079],"(1.5%)":[1081],"60":[1088],"2323":[1090],"(2.6%)":[1092],"0.56;":[1098],"0.40%":[1101],"0.75%).":[1103],"initiated":[1106],"proportion":[1110],"(13":[1115],"4687":[1117],"[0.3%])":[1119],"14":[1122],"2333":[1124],"(0.6%)":[1126],"group,":[1130],"0.45;":[1132],"0.21%":[1135],"0.97%;":[1137],"P<0.05);":[1138],"however,":[1139,1702],"small":[1141],"numbers":[1142,1783],"results":[1146,1171,1451,1816,1910],"should":[1147],"interpreted":[1149],"cautiously.":[1150],"Although":[1151],"confirmed":[1157,1167],"adjudicated":[1159],"during":[1160],"trial,":[1162,1989],"post":[1163],"hoc":[1164],"assessment":[1165,1792],"showed":[1169,1690],"similar":[1170],"(9).":[1172],"More":[1173,1608],"recently,":[1174],"(CANVAS)":[1180],"Program":[1181],"(9)":[1182],"(in":[1186],"contrast":[1187],"EMPA-REG,":[1189],"also":[1192,1239,1368,1589,1775,1957,2064,2142,2183],"prevention":[1197],"cohort)":[1198],"rate":[1205],"(composite":[1210],"causes,":[1215],"nonfatal":[1216,1220],"stroke)":[1221],"than":[1226,1592],"0.75":[1233],"0.97).":[1235],"prespecified.":[1240],"allocated":[1242],"had":[1245,1304],"0.60;":[1280],"0.47":[1283],"0.77).":[1285],"terms":[1287],"CANVAS":[1291,1457,1536],"higher":[1295],"incidence":[1296],"amputations":[1298],"arm,":[1302],"which":[1303,1943],"previous":[1309],"studies.":[1310,1986],"Additional":[1311],"safety":[1316,1422,2190],"prespecified":[1320,1556],"will":[1323,1337,1418,1482,1774,1808,1822,1977,2028,2097,2154,2182],"complete":[1324],"coming":[1326,1812],"years.":[1327],"First,":[1328,1508],"Events":[1334],"(DECLARE)":[1335],"analyze":[1338],"dapagliflozin":[1342,1646,1696,1703,2024],"when":[1346,1814],"added":[1347],"background":[1350],"(and":[1356],"factors).":[1364],"going":[1369],"compared,":[1372],"since":[1373],"captures":[1375],"predefined":[1377,1428],"secondary":[1378,1429],"(sustained":[1382],"death).":[1399],"Finally,":[1400,1915],"Disease":[1415],"(VERTIS)":[1416],"assess":[1419,1752,1851],"ertugliflozin":[1424],"includes":[1426,1881],"endpoint,":[1431],"namely":[1432],"creatinine.":[1444],"Knowledge":[1445],"Gaps":[1446],"Future":[1448,2152],"Studies":[1449],"encouraging":[1460],"regards":[1462],"diabetes.":[1475,1507,1966,2071,2115,2180],"However,":[1476],"there":[1477],"gaps":[1480],"addressed":[1486],"before":[1487],"this":[1488,1496,1948,1968,2105],"strategy":[1489],"can":[1490,1627],"considered":[1492,1512],"routine":[1493],"indication":[1497,2113],"expanded":[1500],"diseases":[1503],"related":[1505,1527],"both":[1509],"above-cited":[1510],"events":[1514,1600],"exploratory":[1516,1558],"and,":[1518],"therefore,":[1519],"designed":[1522,1984],"provide":[1524,2184],"definitive":[1525,1597],"information":[1526,1539,1807,2187],"renoprotection.":[1529],"fact":[1531],"provided":[1537],"regarding":[1540,1610,2188],"recognized":[1546],"surrogate":[1547],"marker":[1548],"highly":[1562],"encouraging,":[1563],"requires":[1565],"confirmation":[1566],"dedicated":[1568,1818,2160],"trials.":[1571],"Importantly,":[1572],"number":[1574],"most":[1580],"clinically":[1581,1732],"relevant":[1582,1621],"progression,":[1587],"far":[1590],"smaller":[1591],"necessary":[1594],"draw":[1596],"conclusions":[1598],"(27":[1599],"21":[1605],"CANVAS).":[1607],"urgently":[1617],"required.":[1618],"Another":[1619],"very":[1620],"unanswered":[1622],"question":[1623],"whether":[1625],"pooled":[1640],"analysis":[1641],"11":[1643],"phase":[1644],"3":[1645,1873],"assessed":[1650],"changes":[1651],"HbA1c,":[1653],"weight,":[1655,1707],"hematocrit":[1658],"24":[1660],"according":[1666],"(eGFR\u226545":[1670],"<60":[1672],"eGFR\u226560":[1677],"<90":[1679],"eGFR\u226590":[1685],"m2)":[1689],"HbA1c-lowering":[1693],"declines;":[1701],"decreases":[1705],"urinary":[1710],"regardless":[1713],"eGFR.":[1715],"Similar":[1716],"findings":[1717],"SGLT2":[1723],"inhibitors,":[1724],"highlight":[1726],"possibility":[1728,2145],"important":[1733,1756,1777,2185],"might":[1735],"differ":[1736],"function.":[1742,1805],"Therefore,":[1743],"properly":[1744],"powered":[1745,2058],"aim":[1750],"(especially":[1759],"ESRD)":[1760],"still":[1762],"crucial":[1763],"understand":[1765],"role":[1767],"It":[1773,1892],"such":[1779],"recruit":[1781],"substantial":[1782],"participants":[1785,1867],"allow":[1791],"consistency":[1795],"otherwise":[1797],"across":[1800],"spectrum":[1802],"years,":[1813],"Nephropathy":[1841],"(CREDENCE)":[1842],"randomized,":[1846],"controlled":[1847],"aiming":[1849],"reducing":[1857],"impairment":[1862],"stage":[1870],"CKD,":[1874,2199],"macroalbuminuria.":[1876],"death.":[1891],"recruited":[1894],"4400":[1896],"participants,":[1897],"majority":[1900],"eGFR<60,":[1902],"expected":[1905],"report":[1907],"main":[1909],"1).":[1914,2054],"shown":[1919],"slow":[1921],"Together":[1933],"action":[1939],"drugs,":[1942],"hemodynamics,":[1947],"observation":[1949],"raises":[1950],"could":[1956],"into":[1959],"improved":[1960],"Whether":[1967],"true,":[1970],"magnitude":[1973],"proven":[1981],"specifically":[1983],"CKD":[2007,2015],"(DAPA":[2008],"CKD),":[2009],"recruiting":[2011],"criterion":[2019],"(half":[2020],"nondiabetic),":[2021],"follow":[2029],"them":[2030],"until":[2031],"time":[2033],"show":[2060,2137],"benefit":[2063],"subgroup":[2067],"Similarly,":[2072],"(including":[2084],"those":[2085],"without":[2088],"diabetes)":[2089],"recently":[2091],"announced":[2093],"(press":[2094],"release),":[2095],"shed":[2098],"light":[2099],"class":[2106,2136],"agents":[2108],"outside":[2109],"Conclusions":[2116],"effective":[2120],"two":[2131],"members":[2132],"studied":[2135],"overall":[2138],"benefit,":[2140],"dramatic":[2147],"protection":[2149],"DM2.":[2151],"hypotheses":[2157],"formally":[2158],"offer":[2166],"dramatically":[2170],"reduce":[2171],"failure":[2176],"They":[2181],"additional":[2186],"efficacy":[2192],"nondiabetic":[2204],"Disclosures":[2207],"Dr.":[2208,2237],"R.P.-F.":[2209],"serves":[2210],"advisory":[2212,2255],"boards":[2213,2256],"speaks":[2215,2258],"scientific":[2217,2260],"meetings":[2218,2261],"Janssen,":[2220,2247,2263],"AstraZeneca,":[2221,2265],"Novartis,":[2222,2279],"Akebia,":[2223],"Baxter,":[2224,2273],"Fresenius":[2226],"Medical":[2227],"Care.":[2228],"He":[2229,2290],"received":[2230],"research":[2231],"grants":[2232],"Baxter":[2234],"Fresenius.":[2236],"V.P.":[2238],"reports":[2239],"serving":[2240,2253],"Steering":[2242],"Committees":[2243],"Boehringer":[2245,2266],"Ingelheim,":[2246,2267],"AbbVie,":[2248,2270],"GlaxoSmithKline":[2249],"Pfizer,":[2251,2282],"Merck,":[2264],"Eli":[2268],"Lilly,":[2269],"Astellas,":[2271],"Bayer,":[2272],"Bristol-Myers":[2274],"Squibb,":[2275],"Durect,":[2276],"Gilead,":[2277],"GlaxoSmithKline,":[2278],"Novo":[2280],"Nordisk,":[2281],"Pharmalink,":[2283],"Relypsa,":[2284],"Roche,":[2285],"Sanofi,":[2286],"Servier,":[2287],"Vitae.":[2289],"policy":[2293],"honoraria":[2295],"being":[2296],"paid":[2297],"his":[2299],"employer.":[2300]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2754469738","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2017-09-25T00:00:00"}
